BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Lipocine Inc. Announces Strengthening Of Its Senior Management Team With Addition Of Robert Merrell As Vice President Of Finance


7/17/2006 1:42:12 PM

SALT LAKE CITY, July 17 /PRNewswire/ -- Lipocine Inc. announced today the appointment of Robert K. Merrell, CPA and graduate of Kellogg Graduate School of Management, as Vice President of Finance. Besides traditional accounting responsibilities, Mr. Merrell will be responsible for financial planning and financing strategy as a part of Lipocine's senior management team.

Most recently, Mr. Merrell was a Vice President at Myriad Genetics Laboratories. Prior to Myriad, Mr. Merrell was CFO at NPS Pharmaceuticals where he was instrumental in taking NPS from an early stage company thru successful IPO and three subsequent follow-on offerings raising approx. $300 million. He was also actively involved in mergers and acquisitions. Prior to NPS, he was a senior manager at KPMG Peat Marwick.

"We are pleased to attract such an experienced and talented executive to Lipocine at this important time," said Dr. Mahesh Patel, President and CEO of Lipocine Inc. "Bob brings a unique blend of expertise in private and public company financing, mergers and acquisitions, and financial management. His experience in leading a small entrepreneurial pharmaceutical/biotech company from very early stage financing through IPO and multiple follow-on offerings will be a tremendous asset to Lipocine going forward as we develop and expand our product portfolio and strengthen our senior management team."

Lipocine Inc. is a pharmaceutical company leveraging its proprietary drug delivery technologies to commercialize innovative pharmaceutical products. Lipocine business objectives are to develop products by improving established drugs to incorporate patient friendly attributes such as faster absorption, lower dose, fewer side effects, less frequent dosing, no food effect. Lipocine has several products available for licensing in key therapeutic areas.

Contact: Jerry Simmons, mail to: gts@lipocine.com Ph: (801) 994-7383 (ext 2110) Lipocine Inc. www.lipocine.com

Lipocine Inc.

CONTACT: Jerry Simmons of Lipocine Inc., +1-801-994-7383, ext. 2110,gts@lipocine.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES